Apogee Therapeutics, Inc. (APGE) has a MoatMap StockRank of 64/100 based on Quality (41/100), Value (37/100), and Momentum (69/100) factor scores. The current signal is HOLD. Apogee Therapeutics, Inc. is a US-based Healthcare company. As a therapeutics company, it's likely a biotech. Biotech often requires significant R&D, is capital intensive, and faces high regulatory and clinical trial risks. This doesn't align well with the asset-light, high ROIC, pricing power criteria of Terry Smith, and the asymmetric opportunity is often tied to specific drug approvals, which is highly speculative and outside the fund's macro-driven approach.